TP53 and small cell lung carcinoma: As a result of TP53 and RB1 inactivation in the vast majority of SCLCs, the upstream and downstream pathways associated with p53 and Rb are disrupted, thereby eliminating their tumor suppressive effects and promoting SCLC development and progression instead (Figure 2).